SEC Form 3 
FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 	  
OMB APPROVAL
OMB Number:	3235-0104	
Estimated average burden	
hours per response:	0.5	

	
1. Name and Address of Reporting Person*
Marstiller Jean W	

(Last)	(First)	(Middle)	
2525 WEST END AVE.	
SUITE 950	

(Street) 
NASHVILLE	TN	37203	

(City)	(State)	(Zip)	
	2. Date of Event Requiring Statement (Month/Day/Year)
08/10/2009 	3. Issuer Name and Ticker or Trading Symbol 
CUMBERLAND PHARMACEUTICALS INC [ CPIX ] 		
		4. Relationship of Reporting Person(s) to Issuer 
(Check all applicable) 
	Director		10% Owner	
X	Officer (give title below)		Other (specify below)	
Sr. VP & Corp. Secretary	
	5. If Amendment, Date of Original Filed (Month/Day/Year)				
			6. Individual or Joint/Group Filing (Check Applicable Line) 
X	Form filed by One Reporting Person	
	Form filed by More than One Reporting Person	
	
Table I - Non-Derivative Securities Beneficially Owned	
1. Title of Security (Instr. 4) 	2. Amount of Securities Beneficially Owned (Instr. 4) 	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 	4. Nature of Indirect Beneficial Ownership (Instr. 5) 	
Common Stock	581,359	D		
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities) 	
1. Title of Derivative Security (Instr. 4) 	2. Date Exercisable and Expiration Date (Month/Day/Year)	3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 	4. Conversion or Exercise Price of Derivative Security 	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 	6. Nature of Indirect Beneficial Ownership (Instr. 5) 	
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares				
Options	01/04/2002	01/04/2012	Common Stock	9,230	1.63	D		
Options	01/31/2003	01/31/2013	Common Stock	400	3.5	D		
Options	04/01/2004	04/01/2014	Common Stock	10,000	6	D		
Options	01/15/2005	01/15/2015	Common Stock	3,000	6	D		
Options	12/31/2005	01/15/2015	Common Stock	3,000	6	D		
Options	12/31/2006	01/15/2015	Common Stock	3,000	6	D		
Options	12/31/2006	06/30/2016	Common Stock	2,750	9	D		
Options	12/31/2007	01/15/2015	Common Stock	3,000	6	D		
Options	12/31/2007	06/30/2016	Common Stock	2,750	9	D		
Options	12/31/2007	02/02/2017	Common Stock	3,000	11	D		
Options	12/31/2008	01/15/2015	Common Stock	3,000	6	D		
Options	12/31/2008	06/30/2016	Common Stock	2,750	9	D		
Options	12/31/2008	07/31/2018	Common Stock	2,250	13	D		
Options	12/31/2008	02/02/2017	Common Stock	3,000	11	D		
Options	12/31/2009	02/02/2017	Common Stock	3,000	11	D		
Options	12/31/2009	06/30/2016	Common Stock	2,750	9	D		
Options	12/31/2009	07/31/2018	Common Stock	2,250	13	D		
Options	12/31/2009	02/16/2019	Common Stock	2,250	13	D		
Options	12/31/2010	02/02/2017	Common Stock	3,000	11	D		
Options	12/31/2010	07/31/2018	Common Stock	2,250	13	D		
Options	12/31/2010	02/16/2019	Common Stock	2,250	13	D		
Option	12/31/2011	07/31/2018	Common Stock	2,250	13	D		
Options	12/31/2011	02/16/2019	Common Stock	2,250	13	D		
Options	12/31/2012	02/16/2019	Common Stock	2,250	13	D		
Explanation of Responses:	
Remarks:	
	
	Jean W. Marstiller	08/10/2009	
	** Signature of Reporting Person	Date	
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).	
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.